Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FIDT-10b PET Imaging in Cardiac Amyloidosis
NCT07835880Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]FIDT-10b in transthyretin amyloid cardiomyopathy (ATTR-CM), immunoglobulin light-chain amyloidosis (AL), sponsored by Peking Union Medical College Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
[18F]FIDT-10b
03
Conditions
transthyretin amyloid cardiomyopathy (ATTR-CM)immunoglobulin light-chain amyloidosis (AL)
Beyond the preview
Go deeper on NCT07835880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07835880.